Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Cash from Operations (2023 - 2026)

Contineum Therapeutics' Cash from Operations history spans 4 years, with the latest figure at 16266000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 12.86% to 16266000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 57166000.0 through Mar 2026, down 45.53% year-over-year, with the annual reading at 55312000.0 for FY2025, 68.4% down from the prior year.
  • Cash from Operations came in at 16266000.0 for Q1 2026, down from 13042000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 40674000.0 in Q2 2023 to a low of 16266000.0 in Q1 2026.
  • The 4-year median for Cash from Operations is 10202000.0 (2024), against an average of 6544153.85.
  • The largest YoY upside for Cash from Operations was 4.69% in 2024 against a maximum downside of 120.9% in 2024.
  • Contineum Therapeutics' Cash from Operations stood at 10704000.0 in 2023, then grew by 4.69% to 10202000.0 in 2024, then fell by 27.84% to 13042000.0 in 2025, then dropped by 24.72% to 16266000.0 in 2026.
  • Per Business Quant, the three most recent readings for CTNM's Cash from Operations are 16266000.0 (Q1 2026), 13042000.0 (Q4 2025), and 12197000.0 (Q3 2025).